What type of Tax Credits and Banking Options can Business Owners expect as the Federal Rescheduling of Cannabis Progresses?

Carpfish Creative
Dec 30, 2025
7 min read

As federal cannabis rescheduling progresses toward a Schedule III classification, cannabis

industry operators can anticipate transformative changes in their tax treatment and financial services access. President Trump's December 18, 2025, Executive Order has accelerated a timeline that will likely culminate in final rescheduling by mid-2026. The operational and financial implications are substantial, though constrained by the reality that rescheduling, while significant, does not constitute federal legalization.

Tax Relief: The End of Section 280E

The most immediate and consequential benefit of Schedule III reclassification is the elimination of Internal Revenue Code Section 280E, which currently prohibits cannabis businesses from deducting ordinary and necessary business expenses. Under the current regime, a cannabis operation with $1 million in revenue, $650,000 in cost of goods sold, and $250,000 in operating expenses faces taxation on $350,000 of gross income, resulting in approximately $105,000 in federal taxes and a net loss of $5,000 after tax.^[1]

The same business operating under post-rescheduling tax rules would deduct the $250,000 in operating expenses, reducing taxable income to $100,000 and federal taxes to $30,000—creating $70,000 in after-tax cash flow. This improvement transforms unit economics for retail dispensaries, cultivation operations, manufacturers, and ancillary services.^[1]

Timing and Retroactivity Considerations

Relief from 280E will almost certainly be prospective—effective once the DEA's final rule becomes official, expected in the first half of 2026. The IRS explicitly stated in 2024 that amended return claims filed in anticipation of rescheduling lack merit. However, businesses can file "protective refund claims" for open tax years (within three years of filing or two years of payment) to preserve their right to claim retroactive relief if Congress or the IRS provides favorable guidance. Any protective claim should be supported by reasonable tax positions and professional advice to avoid penalties.^[2]^[3]^[4]^[5]

Available Federal Tax Credits Post-Rescheduling

Once 280E no longer applies, cannabis businesses gain access to a suite of federal tax credits and deductions previously blocked by their Schedule I classification:

Research and Development (R&D) Credit

The R&D credit is one of the most valuable benefits available to cannabis operators. It provides a dollar-for-dollar credit against tax liability for qualifying research expenses. Eligible activities include:^[6]^[1]

Cultivation method optimization (plant spacing, nutrient formulation, climate control)
Product development and formulation refinement
Extraction technology improvements
Delivery method development (gummies, topicals, edibles, etc.)
Software development for inventory management and compliance

The credit can be claimed under either the traditional method or the alternative simplified credit method, and recent legislative changes have made it more accessible to smaller and medium-sized businesses. Hemp and CBD companies have already demonstrated the credit's utility—federally legal cannabis products have accessed R&D credits, confirming the IRS's willingness to support cannabinoid research once the legal bar is cleared.^[6]

Work Opportunity Tax Credit (WOTC) - Link to learn more

Labor-intensive cannabis operations—retail, cultivation, and manufacturing—can claim WOTC for hiring individuals from targeted groups, including ex-felons, unemployed veterans, and recipients of certain federal assistance programs. The credit functions as a direct reduction in tax liability, making it particularly valuable for cultivators and retailers with seasonal hiring needs.^[7]^[1]

Bonus Depreciation and Capital Deductions

A significant development outside the rescheduling context is the restoration of 100% bonus depreciation through 2030 under the One, Big, Beautiful Bill enacted July 4, 2025. Cannabis operators placing qualified property (equipment, machinery, vehicles, qualified improvement property) into service after January 19, 2025, can now fully expense these assets in the year of acquisition and placement in service. This accelerates cash flow recovery from capital investments in cultivation facilities, processing equipment, and retail build-outs.^[8]

Additionally, Section 179 small business expensing has been increased to $2.5 million with a phase-out threshold of $4 million, providing an alternative for businesses that may not qualify for full bonus depreciation. Cost segregation studies—detailed analyses that break buildings into component asset classes with shorter depreciation periods—become particularly valuable tools for cannabis real estate investments post-rescheduling, as operators can now claim these accelerated write-downs.^[8]^[1]

Qualified Business Income Deduction and Accounting Flexibility

Cannabis pass-through entities (S-corps, partnerships, LLCs) will gain access to the 20% Qualified Business Income (QBI) deduction under Section 199A, previously uncertain due to the 280E classification. Additionally, operators regain flexibility in accounting methods and inventory valuation techniques, allowing for more sophisticated tax planning around expense timing and cost allocation.^[7]

Energy and Clean Energy Credits

While Section 179D (the Energy Efficient Commercial Building Deduction) is being repealed for projects beginning construction after June 30, 2026, cannabis operators can still access federal clean energy credits for investments in energy-efficient lighting, HVAC systems, and renewable energy. These credits remain available and become particularly relevant for indoor cultivation operations, which are energy-intensive.^[8]

Banking and Payment Processing: Progress with Limitations

Rescheduling will improve financial services access, but it does not resolve the core banking challenges facing the industry. Cannabis will remain a federally controlled substance, subject to Bank Secrecy Act (BSA) and anti-money-laundering (AML) compliance requirements.^[9]^[10]

Why Rescheduling Alone Is Not Sufficient

Schedule III classification removes the federal stigma and changes the legal framework for cannabis, but it does not grant cannabis the same federal status as a fully legal business. The 2014 FinCEN guidance that classifies cannabis sales as "high-risk" will remain in effect unless Congress acts. Banks and credit unions will still need to file Suspicious Activity Reports (SARs) on all cannabis transactions, verify licenses, document beneficial ownership, and maintain ongoing compliance monitoring. Major credit card networks (Visa, Mastercard, American Express) will not process cannabis transactions without explicit congressional protections.^[10]^[11]^[9]

Expected Banking Improvements from Rescheduling

Despite these limitations, rescheduling will catalyze incremental improvements:

Expanded participation: More regional and community banks and credit unions may reconsider cannabis relationships as federal risk perceptions decline.^[10]
Enhanced lending: Specialized cannabis lenders (Casa Verde Capital, Merida Meridian, and others) will likely expand product offerings—term loans, working capital facilities, and eventually real estate financing.^[10]
Regulatory clarity: Banks serving cannabis may face lower compliance costs as regulators gain confidence in the framework, potentially reducing account maintenance fees and documentation burdens.^[10]
Relationship stability: Existing cannabis banking relationships should stabilize, reducing the risk of sudden account closures.^[10]

Current Compliant Payment Solutions as of December 2025

Given continued federal restrictions on traditional banking, cannabis retailers operate through specialized compliant payment methods:

Point of Banking (POB): Functions as an at-the-counter ATM where customers access their bank account directly. Customers are typically charged convenience fees (varying by processor), and transactions round to dollar amounts. POB remains the most stable and widely-used payment method. Importantly, retailers using integrated POB solutions (embedded in POS systems) see an average 30% increase in customer basket size, as shoppers are no longer constrained by cash in their pockets. Evolve Payment and Paybotic are leading providers.^[12]^[13]
ACH Transfers: Bank-to-bank electronic transfers that bypass credit card networks entirely. ACH costs 1–1.5% per transaction—significantly lower than POB's convenience fees—and provides direct deposit into the dispensary's account. Modern processors like Flowhub (through Aeropay integration) and Cova have made ACH accessible through QR code checkout and instant bank verification using Plaid technology, improving customer experience.^[13]^[12]
Cash: Remains the largest payment method at most dispensaries, but creates significant security (armed robbery, theft), logistics (armored vehicles, vault costs), and compliance risks. Industry data shows cannabis retailers process approximately $30 billion in annual transactions, with cash dominating but alternative payment methods increasingly preferred.^[13]

The Path to Mainstream Banking: SAFER Banking Act

Real progress toward normal banking access depends on the Secure and Fair Enforcement Regulation (SAFER) Banking Act, which has evolved from the earlier SAFE Banking Act. As of July 2025, the SAFER Banking Act passed the Senate Banking Committee on a bipartisan 14-9 vote and now awaits a full Senate floor vote, expected by year-end 2025. The House has passed versions of the SAFE Banking Act seven times, indicating sustained bipartisan support.^[11]

The SAFER Banking Act would:

Protect banks and credit unions from federal penalties for serving state-legal cannabis businesses
Clarify FinCEN guidance on cannabis account monitoring
Protect account holders, including employees and ancillary service providers
Enable lending for cannabis real estate, equipment, and working capital
Provide regulatory clarity on deposit insurance and account termination

If enacted (realistic scenario for 2026), the SAFER Act would unlock traditional lending, credit card processing pilots through specialty networks, and broader institutional investment. Cannabis operators should monitor this legislation closely, as passage would represent the inflection point for genuine financial services normalization.^[11]

Realistic Timeline and Operator Expectations

2026 (H1): Rescheduling finalized (likely March–May). Operators gain 280E relief for expenses paid or incurred after the effective date. Tax filings reflect new deductibility in 2027 tax year.
2026-2027: SAFER Banking Act passes (high probability). Banks begin establishing cannabis lending programs. Payment processors expand offerings. Regional banks and credit unions enter the market.
2027-2028: Meaningful credit card access via specialty networks for compliant operators. Institutional capital becomes more accessible (venture debt, growth equity, M&A). State-legal operators begin accessing traditional SBA lending and equipment financing.
2028+: Normalization of banking services, though continued AML compliance and monitoring remain. Federal legalization (full descheduling) becomes realistic if rescheduling demonstrates stability and public support.

Recommended Operator Actions Now

For Tax Planning: Begin documenting R&D activities contemporaneously, as the IRS requires detailed records to substantiate credits. Compile hiring data for Work Opportunity Tax Credit claims. Develop financial models under post-280E assumptions to understand valuation upside and reinvestment capacity. Engage a cannabis-specialized CPA to assess cost segregation opportunities and bonus depreciation timing, particularly if you're planning facility investments in 2025-2026.

For Banking and Payments: Maintain relationships with current compliant payment processors (POB or ACH). Ensure your business licenses, standard operating procedures, and internal controls are documented and organized, as banks will expect these materials when rescheduling opens conversations about account relationships. Set up integrated ACH solutions (through Flowhub/Aeropay or Cova) if not already in place, as this reduces human error and improves customer experience over a standalone POB. Begin building clean, beneficial ownership records and compliance files now, reducing friction if your bank requests additional documentation post-rescheduling.

For Operations: Strengthen financial reporting and internal controls to prepare for potential investor interest, institutional lending discussions, and M&A activity. Expect significant consolidation and institutional capital entry within 18–24 months of rescheduling finalization. Operators with audited financials, transparent records, and scalable operations will command premium valuations.

The cannabis industry stands at an inflection point. While rescheduling is not legalization, it removes the federal tax penalty that has suppressed industry profitability and prevents access to mainstream financial services. For operators prepared to capture these opportunities—through diligent tax planning, robust compliance, and strategic positioning—the next 18–36 months represent a transformational window.

Goodwin Law (December 18, 2025) MGO CPA (December 21, 2025) AAFCPA (December 19, 2025) Greenleaf Brief (June 3, 2024) Tax Controversy 360 (May 20, 2024) Corvee (October 17, 2022) Bonadio (December 21, 2025) Plant Moran (July 20, 2025) Abrigo (September 29, 2025) Buchalter (December 18, 2025) Herring Bank (June 1, 2025) Flowhub (September 21, 2025) WebJoint (October 28, 2025)^[3]^[4]^[5]^[12]^[9]^[2]^[6]^[1]^[13]^[7]^[11]^[8]^[10]

⁂ ARTICLE SOURCES